91 – 100 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
(2018) p.221-252
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
(2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018
- Contribution to conference › Abstract
-
Mark
No association of salivary total tau concentration with Alzheimer's disease
- Contribution to journal › Article
-
Mark
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
- Contribution to journal › Article
- 2017
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
- Contribution to journal › Article
-
Mark
Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy
- Contribution to journal › Article
-
Mark
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease
- Contribution to journal › Article
-
Mark
Tau pathology distribution in Alzheimer's disease corresponds differentially to cognition-relevant functional brain networks
- Contribution to journal › Article
